MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
world patient safety day

Celebrating World Patient Safety Day 2024: Improving Diagnosis for a Safer Tomorrow

On World Patient Safety Day 2024, we focus on the critical theme of "Improving Diagnosis...
patient influencers

How Patient Influencers Can Amplify the Pharma Voice

Learn more about patient influencers and their reach and relevance and how you can apply...

Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward

Ensuring that your organization embraces DE & I training is important for cultivating a strong...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
EU MDR,Compliance,Rules,MedTech,Law,Regulation,Policy,Documents,Medical Device

Ensuring Alignment Across EU MDR Deliverables

How to avoid all these pitfalls and keep thriving in the EU Medical Devices market?...
Data-driven QMS Alignment-Feature image for the 30-sec video reel - AMDS

Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR

The latest EU-MDR guidelines are a step in the right direction, moving from a focus...

Learn more ABOUT our company.